Kazia Therapeutics Ltd (KZIA) is down Monday morning, with the stock declining -4.30% in pre-market trading to 1.78. KZIA's short-term technical score of 30 indicates that the stock has traded less bullishly over the last month than 70% of stocks on the market. In the Biotechnology industry, which ranks 107 out of 146 industries, the stock ranks higher than 37% of stocks. Kazia Therapeutics Ltd has fallen 54.30% over the past month, closing at $3.97 on July 11. During this period of time, the stock fell as low as $1.76 and as high as $4.08. KZIA has an average analyst recommendation of Sell. The company has an average price target of $16.00.
KZIA has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on KZIA!